$LGND
LIGAND PHARMACEUTICALS INC

2020 Q2 Form 10-Q Financial Statement

#000088616320000097 Filed on August 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $41.42M $24.99M
YoY Change 65.77% -72.25%
Cost Of Revenue $7.640M $2.405M
YoY Change 217.67% 112.08%
Gross Profit $33.78M $22.58M
YoY Change 49.59% -74.6%
Gross Profit Margin 81.55% 90.37%
Selling, General & Admin $10.07M $10.99M
YoY Change -8.37% 18.3%
% of Gross Profit 29.81% 48.67%
Research & Development $12.73M $12.21M
YoY Change 4.25% 99.07%
% of Gross Profit 37.69% 54.08%
Depreciation & Amortization $4.500M $3.700M
YoY Change 21.62% 23.33%
% of Gross Profit 13.32% 16.38%
Operating Expenses $12.73M $12.21M
YoY Change 4.25% 99.07%
Operating Profit $7.100M -$4.130M
YoY Change -271.91% -105.89%
Interest Expense $6.213M $9.012M
YoY Change -31.06% -33.02%
% of Operating Profit 87.51%
Other Income/Expense, Net $21.02M -$13.90M
YoY Change -251.24% -154.71%
Pretax Income $28.12M -$18.03M
YoY Change -255.97% -118.86%
Income Tax $6.033M -$3.609M
% Of Pretax Income 21.46%
Net Earnings $22.09M -$14.42M
YoY Change -253.17% -119.71%
Net Earnings / Revenue 53.32% -57.71%
Basic Earnings Per Share $1.38 -$0.74
Diluted Earnings Per Share $1.32 -$0.74
COMMON SHARES
Basic Shares Outstanding 16.06M shares 19.56M shares
Diluted Shares Outstanding 16.69M shares 19.56M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $809.9M $1.392B
YoY Change -41.83% 36.95%
Cash & Equivalents $115.2M $273.0M
Short-Term Investments $694.7M $1.119B
Other Short-Term Assets $5.489M $5.672M
YoY Change -3.23% -55.75%
Inventory $3.702M $9.638M
Prepaid Expenses
Receivables $41.87M $20.30M
Other Receivables $2.700M $0.00
Total Short-Term Assets $863.6M $1.442B
YoY Change -40.12% -2.58%
LONG-TERM ASSETS
Property, Plant & Equipment $7.883M $6.268M
YoY Change 25.77% 49.7%
Goodwill $103.4M $88.00M
YoY Change 17.46% 2.37%
Intangibles $215.3M $212.6M
YoY Change 1.26% -4.23%
Long-Term Investments $60.38M
YoY Change
Other Assets $6.059M $1.680M
YoY Change 260.65% 161.68%
Total Long-Term Assets $379.3M $359.5M
YoY Change 5.5% -4.84%
TOTAL ASSETS
Total Short-Term Assets $863.6M $1.442B
Total Long-Term Assets $379.3M $359.5M
Total Assets $1.243B $1.802B
YoY Change -31.02% -3.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.103M $2.888M
YoY Change 111.32% 7.68%
Accrued Expenses $12.83M $11.54M
YoY Change 11.16% 23.93%
Deferred Revenue $8.917M $939.0K
YoY Change 849.63% -44.76%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $27.10M
YoY Change -87.12%
Total Short-Term Liabilities $29.26M $109.0M
YoY Change -73.15% -82.78%
LONG-TERM LIABILITIES
Long-Term Debt $449.7M $624.2M
YoY Change -27.96% 4.75%
Other Long-Term Liabilities $26.47M $7.692M
YoY Change 244.14% 392.13%
Total Long-Term Liabilities $26.47M $7.692M
YoY Change 244.14% 392.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.26M $109.0M
Total Long-Term Liabilities $26.47M $7.692M
Total Liabilities $547.9M $760.4M
YoY Change -27.94% -38.6%
SHAREHOLDERS EQUITY
Retained Earnings $392.9M $422.7M
YoY Change -7.06% -266.27%
Common Stock $16.00K $19.00K
YoY Change -15.79% -9.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $695.0M $1.041B
YoY Change
Total Liabilities & Shareholders Equity $1.243B $1.802B
YoY Change -31.02% -3.04%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $22.09M -$14.42M
YoY Change -253.17% -119.71%
Depreciation, Depletion And Amortization $4.500M $3.700M
YoY Change 21.62% 23.33%
Cash From Operating Activities $24.40M -$61.10M
YoY Change -139.93% -183.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$26.70M $265.8M
YoY Change -110.05% -145.31%
Cash From Investing Activities -$26.70M $265.8M
YoY Change -110.05% -145.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -37.60M
YoY Change -100.0% -106.13%
NET CHANGE
Cash From Operating Activities 24.40M -61.10M
Cash From Investing Activities -26.70M 265.8M
Cash From Financing Activities 0.000 -37.60M
Net Change In Cash -2.300M 167.1M
YoY Change -101.38% 66.27%
FREE CASH FLOW
Cash From Operating Activities $24.40M -$61.10M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000886163
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201613Member
CY2020Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P7Y
CY2020Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P7Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33093
dei Entity Registrant Name
EntityRegistrantName
LIGAND PHARMACEUTICALS INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0160744
dei Entity Address Address Line1
EntityAddressAddressLine1
3911 Sorrento Valley Boulevard, Suite 110
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
550-7500
dei Security12b Title
Security12bTitle
Common Stock , par value $0.001 per share
dei Trading Symbol
TradingSymbol
LGND
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23340000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32937000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9181000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9970000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26471000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22480000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
547933000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
727683000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Assets Current
AssetsCurrent
863624000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1123645000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
26411000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25608000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
215295000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
210448000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
103369000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
95229000 USD
CY2020Q2 lgnd Commercial License Rights
CommercialLicenseRights
10606000 USD
CY2019Q4 lgnd Commercial License Rights
CommercialLicenseRights
20090000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7883000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7185000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9689000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10353000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6059000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2357000 USD
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q2 us-gaap Assets
Assets
1242936000 USD
CY2019Q4 us-gaap Assets
Assets
1494915000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6103000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2420000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12828000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9836000 USD
CY2020Q2 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
1416000 USD
CY2019Q4 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
2607000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8917000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2139000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
29264000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17002000 USD
CY2020Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
449672000 USD
CY2019Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
638959000 USD
CY2020Q2 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
10005000 USD
CY2019Q4 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
6335000 USD
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16078143 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115156000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71543000 USD
CY2020Q2 us-gaap Short Term Investments
ShortTermInvestments
694724000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
998324000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41874000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
30387000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
3702000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
7296000 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2679000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11361000 USD
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5489000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4734000 USD
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16071000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16071000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16823000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16823000 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
17000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
304404000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
367326000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2310000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-216000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
392893000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
400105000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
695003000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
767232000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1242936000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1494915000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
41420000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24987000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74581000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
68471000 USD
CY2020Q2 us-gaap Cost Direct Material
CostDirectMaterial
7644000 USD
CY2019Q2 us-gaap Cost Direct Material
CostDirectMaterial
2405000 USD
us-gaap Cost Direct Material
CostDirectMaterial
12327000 USD
us-gaap Cost Direct Material
CostDirectMaterial
6263000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2019Q2 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
3875000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
3505000 USD
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
7410000 USD
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
7008000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12732000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12213000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24623000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23502000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10069000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10994000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19333000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22082000 USD
CY2020Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
34320000 USD
CY2019Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
29117000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
63693000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
58855000 USD
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0 USD
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
812797000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7100000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4130000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
10888000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
822413000 USD
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
23460000 USD
CY2019Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-15061000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
-7281000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
4488000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1969000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
9285000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
6699000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
15194000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
6213000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
9012000 USD
us-gaap Interest Expense
InterestExpense
14761000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
22086000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14419000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2045000 USD
us-gaap Interest Expense
InterestExpense
17918000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1803000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
890000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2159000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
508000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21019000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13898000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13184000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2272000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
28119000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18028000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2296000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
824685000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6033000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3609000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-251000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
172767000 USD
us-gaap Net Income Loss
NetIncomeLoss
651918000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.38
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
32.60
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16055000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19558000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16292000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20000000 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
31.34
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16694000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19558000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16292000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20799000 shares
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
22086000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5653000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14419000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2045000 USD
us-gaap Net Income Loss
NetIncomeLoss
651918000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2742000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
503000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-30000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
733000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-185000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-542000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2064000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-251000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24643000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14458000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4139000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
652400000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
767232000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1008000 USD
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
151585000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
73287000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-2772000 USD
CY2020Q1 lgnd Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment
AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
-1879000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-2745000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-24131000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
661896000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1128000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7359000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
2742000 USD
CY2020Q2 lgnd Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment
AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
-185000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-23000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
22086000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
695003000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
560914000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-991000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5347000 USD
CY2019Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
230000 USD
CY2019Q1 lgnd Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment
AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
291000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-569000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
666337000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1079974000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
740000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6571000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
33717000 USD
CY2019Q2 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
503000 USD
CY2019Q2 lgnd Adjustments To Additional Paid In Capital Foreign Currency Translation Adjustment
AdjustmentsToAdditionalPaidInCapitalForeignCurrencyTranslationAdjustment
-542000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2343000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14419000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1041453000 USD
us-gaap Profit Loss
ProfitLoss
-2045000 USD
us-gaap Profit Loss
ProfitLoss
651918000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
812797000 USD
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
371000 USD
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-984000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7869000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7699000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1198000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6023000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12442000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
14999000 USD
lgnd Amortization Of Other Economic Rights
AmortizationOfOtherEconomicRights
2733000 USD
lgnd Amortization Of Other Economic Rights
AmortizationOfOtherEconomicRights
5452000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
659000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13012000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11918000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
8890000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-55661000 USD
lgnd Gain Loss On Short Term Investments
GainLossOnShortTermInvestments
-7281000 USD
lgnd Gain Loss On Short Term Investments
GainLossOnShortTermInvestments
4488000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1499000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-4429000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11466000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35591000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6977000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4573000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2909000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3764000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8673000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
47455000 USD
lgnd Increase Decrease In Other Economic Rights
IncreaseDecreaseInOtherEconomicRights
0 USD
lgnd Increase Decrease In Other Economic Rights
IncreaseDecreaseInOtherEconomicRights
12000000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3140000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
597000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41304000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15800000 USD
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
0 USD
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
812797000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
336726000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1281274000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
179431000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
43724000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
452405000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
791006000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
15140000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1809000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5673000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
281779000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
360580000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
203210000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1550000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2643000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1429000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2893000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
73287000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
189917000 USD
lgnd Payments To Contingent Value Right Holders Financing Activity
PaymentsToContingentValueRightHoldersFinancingActivity
1800000 USD
lgnd Payments To Contingent Value Right Holders Financing Activity
PaymentsToContingentValueRightHoldersFinancingActivity
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1134000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-279310000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-190167000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-160000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
43613000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
154620000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72273000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119780000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115886000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
274400000 USD
us-gaap Interest Paid Net
InterestPaidNet
2531000 USD
us-gaap Interest Paid Net
InterestPaidNet
2915000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
69703000 USD
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
730000 USD
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1353000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
292000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3553000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
lgnd Shares Reacquired In Hedge Transaction Value
SharesReacquiredInHedgeTransactionValue
-38000 USD
lgnd Shares Reacquired In Hedge Transaction Value
SharesReacquiredInHedgeTransactionValue
938000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Reclassifications</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, effective the first quarter of 2020, we began to present service revenue and contract revenue separately, which were combined in license fees, milestones and other revenues in prior years. As a result, service revenue and contract revenue in the condensed consolidated statements of operations for the three and six months ended June 30, 2019 have been reclassified to conform to the current period presentation. In addition, effective the second quarter of 2020, we began to include our investment in Viking in “short-term investments” in the condensed consolidated balance sheet as of June 30, 2020, and present “gain (loss) from short-term investments” in the condensed consolidated statements of operations for the three and six months ended June 30, 2020 to include both the gain (loss) from investment in Viking and other short-term investments, which was previously included in “other income, net”. As a result, the audited consolidated balance sheet as of December 31, 2019 and the condensed consolidated statements of operations for the three and six months ended June 30, 2019 have been reclassified to conform to the current period presentation.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div>
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2000000.0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2400000 USD
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2700000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4100000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
41420000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24987000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74581000 USD
CY2020Q2 lgnd Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Rolling After Five Years Fair Value
DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsFairValue
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
68471000 USD
CY2020Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni Amortized Cost
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost
643813000 USD
CY2020Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
1291000 USD
CY2020Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
2731000 USD
CY2020Q2 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
642373000 USD
CY2019Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni Amortized Cost
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAmortizedCost
941174000 USD
CY2019Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
933000 USD
CY2019Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
2118000 USD
CY2019Q4 lgnd Debt Securities Available For Sale And Equity Securities Fvni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
939989000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
414505000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
414905000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
73579000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
73509000 USD
CY2020Q2 lgnd Debt Securities Available For Sale Maturity Allocated And Single Maturity Date Rolling After Five Years Amortized Cost
DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateRollingAfterFiveYearsAmortizedCost
0 USD
CY2020Q2 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
488084000 USD
CY2020Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
488414000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
150000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
46037000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
150000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
46037000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
19000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
137947000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
19000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
137947000 USD
CY2020Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
7 position
CY2020Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2020Q2 lgnd Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease
COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
100000 USD
lgnd Covid19 Accounts Receivable Allowance For Credit Loss Period Increase Decrease
COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
300000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
103369000 USD
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
318664000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
95229000 USD
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
305677000 USD
CY2020Q1 lgnd Commercial License And Other Economic Rights Allowance For Credit Loss
CommercialLicenseAndOtherEconomicRightsAllowanceForCreditLoss
5500000 USD
CY2020Q2 lgnd Commercial License And Other Economic Rights Increase Decrease To Allowance For Credit Loss During Period
CommercialLicenseAndOtherEconomicRightsIncreaseDecreaseToAllowanceForCreditLossDuringPeriod
500000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3457000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1986000 USD
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
964000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1135000 USD
CY2020Q2 lgnd Licensee Accrual Current
LicenseeAccrualCurrent
413000 USD
CY2019Q4 lgnd Licensee Accrual Current
LicenseeAccrualCurrent
381000 USD
CY2020Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1038000 USD
CY2019Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
0 USD
CY2020Q2 lgnd Returns Accrual
ReturnsAccrual
2899000 USD
CY2019Q4 lgnd Returns Accrual
ReturnsAccrual
3027000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1728000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1242000 USD
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
471000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
690000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1858000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1375000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12828000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9836000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7359000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
6571000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13012000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
11918000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.69
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.43
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y1M6D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M12D
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16055000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19558000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16292000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
40000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
38000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
599000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
761000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16694000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19558000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16292000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20799000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7832000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7457000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8988000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7243000 shares
CY2020Q2 lgnd Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
642373000 USD
CY2019Q4 lgnd Short Term Investments Fair Value Disclosure
ShortTermInvestmentsFairValueDisclosure
939989000 USD
CY2020Q2 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
43535000 USD
CY2019Q4 us-gaap Notes Receivable Fair Value Disclosure
NotesReceivableFairValueDisclosure
48425000 USD
CY2020Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
8816000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
9910000 USD
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
694724000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
998324000 USD
CY2020Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
107000 USD
CY2019Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
75000 USD
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
11528000 USD
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9017000 USD
CY2020Q1 lgnd Paymentsto Contingent Value Right Holdersand Other Contingency Payments Investing Activities
PaymentstoContingentValueRightHoldersandOtherContingencyPaymentsInvestingActivities
1800000 USD
CY2010Q1 lgnd Number Of Contingent Value Rights Series
NumberOfContingentValueRightsSeries
4 contingentValueRightSeries
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 acquisition
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.215
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.109
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.200
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.209
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1500000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
69.79
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
73300000 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 USD
CY2019Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0 USD
CY2019Q3 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2020Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
253500000 USD

Files In Submission

Name View Source Status
0000886163-20-000097-index-headers.html Edgar Link pending
0000886163-20-000097-index.html Edgar Link pending
0000886163-20-000097.txt Edgar Link pending
0000886163-20-000097-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lgnd-20200630.htm Edgar Link pending
lgnd-20200630.xsd Edgar Link pending
lgnd-20200630_cal.xml Edgar Link unprocessable
lgnd-20200630_def.xml Edgar Link unprocessable
lgnd-20200630_g1.jpg Edgar Link pending
lgnd-20200630_htm.xml Edgar Link completed
lgnd-20200630_lab.xml Edgar Link unprocessable
lgnd-20200630_pre.xml Edgar Link unprocessable
lgnd63020exhibit311.htm Edgar Link pending
lgnd63020exhibit312.htm Edgar Link pending
lgnd63020exhibit321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending